Anna Mowry is CFO & Treasurer at Nautilus Biotechnology, Inc. (NAUT). They have made 5 open-market trades across 1 company since 2021, most recently 2025-05-29.
CIK 0001856938
5 open-market purchases totalling $271K since 2021, never a sale. Across 5 scored buys the stock is down 22.9% at ninety days, and 22.4 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NAUT | 83,000 | $171K |
Shares reported on the most recent Form 4, priced at the 2025-06-02 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 60% | 0% |
| Avg Move | +0.8% | +3.0% | -22.9% |
| Alpha | +0.7% | +1.6% | -22.4% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NAUT | BUY | 2025-05-29 | 2025-06-02 | $0.77 | $12K | -4.8% | +4.4% | -10.3% |
| NAUT | BUY | 2022-08-19 | 2022-08-22 | $2.30 | $40K | -1.8% | -2.3% | -19.5% |
| NAUT | BUY | 2022-06-27 | 2022-06-28 | $2.75 | $15K | +8.8% | +4.0% | -27.9% |
| NAUT | BUY | 2021-11-24 | 2021-11-24 | $4.58 | $69K | +4.7% | +19.2% | -24.4% |
| NAUT | BUY | 2021-08-12 | 2021-08-16 | $7.71 | $135K | -2.9% | -10.6% | -32.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.